Immediate Evaluation for Drug-Induced Hepatotoxicity
Stop all anti-tubercular therapy immediately and check liver function tests (ALT, AST, bilirubin) along with a complete blood count—fever and weakness during ATT most commonly indicate drug-induced hepatotoxicity, which can be life-threatening if not promptly recognized.
Initial Assessment Algorithm
When a patient on ATT presents with fever and weakness, follow this structured approach:
1. Immediate Laboratory Testing
- Liver function tests: ALT, AST, bilirubin, alkaline phosphatase 1
- Complete blood count: Check for eosinophilia (DRESS syndrome concern) 2
- Renal function: Creatinine and electrolytes
- Viral hepatitis panel: Hepatitis A, B, C to exclude coexistent viral hepatitis 1
2. Clinical Evaluation Specifics
Look for these key features:
- Jaundice (visible or subclinical)
- Vomiting not directly related to medication timing
- Abdominal pain (right upper quadrant tenderness)
- Rash (suggests DRESS syndrome or drug hypersensitivity) 3, 2
- Severity of weakness (ability to perform daily activities)
- Pattern of fever (persistent vs. intermittent)
Management Based on Laboratory Results
If ALT/AST ≥5× Upper Limit of Normal OR Any Bilirubin Elevation:
Stop rifampicin, isoniazid, and pyrazinamide immediately 1
For Unwell Patients or Smear-Positive TB:
- Admit as inpatient for monitoring 1
- Switch to streptomycin + ethambutol until liver function normalizes 1
- Monitor liver function and clinical status daily
- Ensure appropriate renal and visual monitoring for these alternative drugs 1
For Stable Patients with Non-Infectious TB:
- Hold all treatment until liver function normalizes 1
- Monitor liver function weekly
- No interim therapy needed if clinically stable
If ALT/AST 3-5× Upper Limit of Normal WITH Symptoms:
- Stop all hepatotoxic drugs (rifampicin, isoniazid, pyrazinamide) 4
- Evaluate for other causes of hepatitis
- Consider interim therapy based on clinical severity
If ALT/AST 2-5× Upper Limit of Normal WITHOUT Symptoms:
- Continue current regimen but monitor liver function weekly for 2 weeks, then every 2 weeks 1
- Educate patient to report any new symptoms immediately
- If levels rise further, manage as above
Drug Rechallenge Protocol (After LFTs Normalize)
Once liver function returns to normal, reintroduce drugs sequentially with daily monitoring 1:
Isoniazid first:
- Start 50 mg/day
- Increase to 300 mg/day after 2-3 days if no reaction
- Continue for 2-3 days
Rifampicin second (if no reaction to isoniazid):
- Start 75 mg/day
- Increase to 300 mg after 2-3 days
- Then to 450 mg (<50 kg) or 600 mg (>50 kg) after another 2-3 days
Pyrazinamide last (if no reaction to rifampicin):
- Start 250 mg/day
- Increase to 1.0 g after 2-3 days
- Then to 1.5 g (<50 kg) or 2.0 g (>50 kg)
If reaction recurs: Permanently exclude the offending drug and use alternative regimen under specialist supervision 1
Alternative Diagnoses to Consider
DRESS Syndrome
- Presents with fever, rash, eosinophilia, and systemic organ involvement 3, 2
- Can cause perimyocarditis (rare but life-threatening) 2
- Requires immediate cessation of all ATT and systemic corticosteroids
- Check eosinophil count urgently
Paradoxical Reaction/IRIS
- Occurs within first 2-3 months of therapy 5, 6, 7
- Worsening symptoms despite appropriate treatment
- Diagnosis of exclusion: Must rule out drug resistance, malabsorption, and non-adherence first 5
- Continue ATT; add NSAIDs for mild cases or corticosteroids for severe cases 5
Other Infections
- Viral hepatitis (check serology) 1
- Superinfection
- HIV-related complications (if applicable)
Critical Pitfalls to Avoid
- Never assume symptoms are "just side effects" without checking liver function—drug-induced hepatitis can progress rapidly to liver failure
- Do not continue hepatotoxic drugs if ALT/AST ≥5× normal or any bilirubin elevation 1
- Do not rechallenge drugs until liver function completely normalizes 1
- Do not assume paradoxical reaction without excluding drug resistance and hepatotoxicity first 5
- In a 14-year-old (<50 kg), ensure weight-based dosing adjustments during rechallenge 1
Specialist Consultation
Contact TB specialist or regional TB consultation center if:
- Severe hepatotoxicity requiring alternative regimen design
- Multiple drug intolerances
- Suspected drug resistance
- DRESS syndrome or severe systemic reaction
- Paradoxical reaction requiring corticosteroids 4
The priority is preventing mortality from fulminant hepatic failure while maintaining effective TB treatment—when in doubt, stop hepatotoxic drugs and seek expert guidance.